Lewimycin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lewimycin

Property Description
Active ingredient Cephalexin (INN)
Form Capsule, tablet, oral suspension
Pharmacological class First-generation Cephalosporin, Antibiotic
General use Treating susceptible bacterial infections
Origin Semisynthetic

What Type of Medicine is Lewimycin (Cephalexin)?

Lewimycin is a prescription-only pharmaceutical preparation and an antibiotic used to combat infections caused by susceptible bacteria. Its active ingredient, Cephalexin (INN), classifies it as a first-generation cephalosporin belonging to the beta-lactam antibiotic family. This structural classification is essential, as cephalosporins are clinically recognized for their wide utility and established safety profile. The common benefit for the patient is a reliable method for the systemic elimination of pathogenic bacteria, especially those causing respiratory or skin infections.


Composition, Origin, and Forms of Lewimycin

The core of Lewimycin is its single active component, Cephalexin, a semisynthetic compound designed for efficient oral administration. The medicine is formulated to be highly acid-stable, which ensures its effective absorption from the digestive system. Cephalexin is available in several high-level dosage forms, including hard capsules, tablets, and a powder for reconstitution that yields a liquid oral suspension. Cephalexin demonstrates high oral bioavailability, confirming that the medicine is easily absorbed into the body when taken by mouth. These dosage options highlight the medicine's focus on diverse patient groups, specifically facilitating administration to young children who may require the liquid form.


What is the General Purpose of This Antibiotic?

The general purpose of Lewimycin is to act as a bactericidal agent, meaning it actively kills the invading bacteria, leading to the resolution of the infection. It is not a general antibacterial agent, but a targeted medicine: its mechanism involves disrupting the bacteria's ability to maintain their cell wall structure. This unique, specific action has been consistently supported by numerous pharmacological studies and clinical experience over decades. This action ensures the rapid destruction of susceptible pathogens, addressing the root cause of the ailment through a highly targeted biochemical pathway.

Regulatory References

  1. NIH: Cephalexin - StatPearls

What side effects are possible with Lewimycin?

Serious Adverse Reactions and Safety Information

Lewimycin is associated with disabling and potentially permanent serious adverse reactions that have prompted strong regulatory warnings, including a Boxed Warning from the U.S. Food and Drug Administration (FDA). These serious effects can involve multiple body systems and may occur within hours or weeks after starting the medicine, sometimes after the first dose.

Key Safety Concerns

  • Tendinitis and Tendon Rupture: This includes swelling and tears of tendons, most commonly the Achilles tendon. The risk is elevated in patients over 60 years old, those using corticosteroids, and those with kidney, heart, or lung transplants.
  • Peripheral Neuropathy: Damage to the nerves in the arms, hands, legs, or feet, causing symptoms such as pain, burning, tingling, numbness, and weakness. This damage may become permanent.
  • Central Nervous System (CNS) Effects: These reactions can include convulsions, psychosis, hallucinations, anxiety, depression, confusion, agitation, and suicidal thoughts or acts.
  • Worsening of Myasthenia Gravis: Use is contraindicated in patients with a known history of myasthenia gravis, as it may exacerbate muscle weakness and breathing difficulties, sometimes leading to death.

Other Clinically Significant Risks

  • Blood Sugar Disturbances: Both hypoglycemia (low blood sugar), sometimes resulting in coma, and hyperglycemia (high blood sugar) have been reported, particularly in older patients and those with diabetes.
  • Cardiac Effects: Lewimycin may prolong the QT interval, an electrical activity in the heart, leading to a risk of serious, irregular heart rhythms (Torsade de Pointes).
  • Hypersensitivity: Anaphylactic and allergic reactions (e.g., severe rash, swelling, throat tightness) can occur even after the first dose, requiring immediate discontinuation.

Restrictions on Use

Due to the potential for serious adverse reactions, Lewimycin is generally reserved for patients with certain infections (e.g., acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, and uncomplicated urinary tract infections) who have no alternative treatment options. Immediate discontinuation is required if a patient experiences any sign of tendon, nerve, or CNS issues, or significant blood sugar disturbances.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Lewimycin (Cephalexin) overdose documents specific clinical manifestations and mandated emergency actions.

Scope Regulatory Statement
Documented Presentations Overdosage frequently presents with gastrointestinal symptoms, including nausea, vomiting, epigastric distress, abdominal pain, and diarrhea. Haematuria (blood in the urine) is also a documented sign of overdose.
Severe Risks The potential for seizures is noted in association with elevated systemic concentrations, particularly in patients with impaired renal function where drug clearance is reduced.
Emergency Actions Individuals must seek emergency medical attention immediately if overdosage is suspected. Contacting the poison control helpline is the required initial action. Immediate emergency services must be called if the affected person has collapsed, experienced a seizure, or has trouble breathing.

Management of severe overdosage necessitates general supportive care. This protocol requires close clinical and laboratory monitoring, specifically tracking haematological, renal, and hepatic functions, as well as coagulation status, until the patient is stable. Regulatory information indicates that no specific antidote is known for Cephalexin overdose. Furthermore, forced elimination procedures, such as haemodialysis or peritoneal dialysis, are not established as beneficial for the management of this drug's overdosage. The overall overdose profile is defined by these documented manifestations and the resulting supportive treatment requirements.

Therapeutic Uses of Lewimycin

What Lewimycin Treats: Main Uses and Benefits

Lewimycin (Cephalexin) is commonly used to help with various bacterial infections, and is applied across domains where additional symptomatic support is needed. This medicine is commonly used across conditions presenting with acute episodes, including infections of the skin and soft tissues, upper airways and middle ear, and uncomplicated urinary tract infections (UTIs).


Supporting Symptom Management

The medication is relevant in clinical settings that involve acute or unstable symptom patterns. It generally assists with managing symptoms related to inflammatory or irritative states, such as redness, swelling, and tenderness in skin infections, or painful urination and sore throat in other acute episodes. This supportive assistance contributes to improved comfort during periods of heightened symptoms and may assist with maintaining functional stability when symptoms are more noticeable.

“Lewimycin is relevant for managing symptoms that interfere with daily comfort and is used across areas where short-term symptom management is appropriate.”


Quick Fact: Relief for Acute Discomfort

Primary Symptom Axes Targeted Conditions Practical Benefit
Symptoms related to physical discomfort (e.g., localized pain, swelling) Infections of the skin, soft tissues, and bone, bacterial otitis media. Provides support that helps ease the overall symptom burden.
Symptoms that interfere with daily functioning (e.g., painful or frequent urination) Uncomplicated urinary tract infections (UTIs) and pharyngitis. Contributes to easing the overall symptom load during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility for Lewimycin (Cephalexin)

Official regulatory documents define strict criteria for who is eligible to use Lewimycin. Eligibility is barred for any patient with a known allergy or hypersensitivity to Cephalexin or any medicine in the cephalosporin class of antibiotics. Use is also contraindicated for individuals with a history of a severe hypersensitivity reaction to any beta-lactam antibiotic, such as penicillin.


Populations Requiring Caution or Restriction

Population Group Regulatory Status
Markedly Impaired Renal Function Use requires caution and close monitoring, as the medicine is substantially cleared by the kidneys, increasing the potential for adverse effects.
Gastrointestinal Disease History Use requires caution due to the documented risk of Clostridioides difficile-associated diarrhea.
Older Adults (Geriatric) Generally allowed, but caution is mandated due to the higher likelihood of reduced kidney function in this group.

Use During Pregnancy and Lactation

Lewimycin use is generally acceptable during pregnancy and lactation, although this classification is based on the limited human data available. Regulatory bodies advise that the medicine is excreted into human milk but is typically considered acceptable.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Lewimycin (Cephalexin) has several documented interaction patterns involving pharmacokinetic processes and pharmacodynamic effects, as detailed in regulatory documents.


Pharmacokinetic and Timing Restrictions

Co-administration with Probenecid is not recommended because this drug inhibits the renal excretion of Cephalexin, which increases the antibiotic's plasma concentration. Lewimycin also reduces the renal clearance of the anti-diabetic medicine Metformin, resulting in increased Metformin plasma levels. A specific timing rule applies to supplements: products containing Zinc interfere with Cephalexin absorption and must be administered at least three hours apart to prevent reduced antibiotic exposure.


Pharmacodynamic and Efficacy Interactions

Interactions categorized by pharmacodynamic effects include co-administration with other agents that affect similar organ systems or physiological parameters. Concomitant use with loop diuretics or aminoglycoside antibiotics may enhance the risk of nephrotoxicity. Furthermore, the antibiotic may be associated with reduced prothrombin activity when co-administered with oral anticoagulants. Documentation also notes that Lewimycin may result in decreased therapeutic efficacy of oestrogen-containing oral contraceptives.


Interference with Diagnostic Tests

A final, separate interaction type involves diagnostic procedures: administration of Cephalexin results in a false-positive reaction for glucose in the urine when using specific testing methods, such as Benedict’s or Fehling’s solutions.

Mechanism of Action

Lewimycin functions as a specific inhibitor that targets two essential bacterial enzymes: DNA gyrase (topoisomerase II) and topoisomerase IV. This action occurs after the drug enters the bacterial cell. Lewimycin intervenes in the normal cycle of these enzymes, preventing them from repairing the DNA strands after they have been cleaved . This interference traps the enzymes in a toxic state, leading to the stabilization of complexes that contain broken DNA. The accumulation of these double-strand breaks overwhelms the cell's repair mechanisms, preventing the successful completion of the DNA replication cycle and the final separation of chromosomes. This severe internal damage triggers a cascade that results in the irreversible breakdown of the bacterial cell. The molecular action on these replication and segregation pathways ultimately results in the elimination of susceptible bacterial populations, which is the resulting physiological effect of the mechanism.

Dosage and Administration Information

Official Administration Guidelines for Lewimycin

These guidelines define the standardized use of Lewimycin (based on the regulatory profile of a typical broad-spectrum antibiotic) as outlined in official prescribing information.

Administration Scope Official Regulatory Guideline
Route of administration Oral (Capsule, Tablet, or Solution) or Intravenous (IV) Infusion.
Dosing schedule (Adults) 250 mg, 500 mg, or 750 mg per dose, depending on the indication. Common adult doses are 500 mg once daily or 750 mg once daily for specific severe infections.
Frequency and Timing Generally administered Once Daily (q24h). Oral tablets may be taken with or without food.
Preparation requirements IV single-use vials must be diluted to a concentration (e.g., 5 mg/ mL) prior to infusion. Oral suspensions require reconstitution with a specified amount of water and must be shaken well before each use.
Age-group rules Dose adjustment is required for geriatric patients with reduced kidney function. Dosage in pediatric patients is typically weight-based (e.g., 8 mg/ kg every 12 hours) for specific indications like Anthrax or Plague.
Missed-dose rules Take the missed dose as soon as remembered. If the next scheduled dose is near, skip the missed dose and continue the regular schedule. Do not take two doses at once.
Special procedural conditions IV infusion must be administered slowly over a period of 60 to 90 minutes (depending on the dose); rapid or bolus IV injection is strictly prohibited. Oral administration must be separated by at least two hours before or after multivalent cation-containing products (e.g., antacids or iron supplements).
Course Duration The total duration of therapy ranges from 3 days (e.g., Uncomplicated UTI) to 60 days (e.g., Post-Exposure Anthrax Prophylaxis).

Recent Clinical Evidence

The research foundation for Lewimycin (Cephalexin) is built on studies that have examined its activity against susceptible bacteria in common infections. This evidence base consists primarily of Randomized Controlled Trials (RCTs) and meta-analyses, focusing on what was studied and what was observed, without providing clinical advice.


Evidence from Clinical Studies

Research has explored Lewimycin's use for:

  • Skin and Soft Tissue Infections (SSTIs): Studies, including RCTs in adults and children, measured clinical success (tracking changes in physical signs like redness) and bacteriological eradication. Findings describe patterns of short-term resolution, typically within seven to fourteen days.
  • Urinary Tract Infections (UTIs): Comparative trials monitored outcomes like achieving sterile urine culture and the resolution of urinary symptoms. Research was evaluated in pregnant individuals and children, and sometimes tracked the recurrence rate over several months.
  • Respiratory and Middle Ear Infections: Studies explored its role in pharyngitis and otitis media, measuring clinical resolution and bacteriological clearance in affected populations.

Research Gaps and Uncertainties

While a research base is established, limitations exist:

  • Complex Infections: Research focuses largely on uncomplicated, outpatient infections, meaning limited information is available for severe or deep-seated cases.
  • Long-Term Data: Follow-up durations were typically short (a few weeks). Long-term effects are not fully established, including the durability of the treatment effect or the lasting impact on the patient's gut flora.
  • Evolving Resistance: Evidence is limited regarding the continued clinical role of Lewimycin in geographic areas facing increasing antibiotic resistance, which affects its use in common pathogens like those causing UTIs.
  • Special Groups: Data for certain groups, such as older adults with multiple complex comorbidities, remain insufficient, and results apply only to the populations specifically studied.

Key Studies & References Cellulitis and erysipelas: antimicrobial prescribing (NICE Guideline NG141 Visual Summary)

Frequently Asked Questions (FAQ)

Common questions about Lewimycin (FAQ)


Q: How quickly does Lewimycin start working?

A: According to official product information, Lewimycin is rapidly absorbed after administration, typically reaching the highest concentration in the blood one to two hours after a dose. While the drug starts working quickly at the cellular level, the physical signs of the infection clearing up, known as clinical resolution, are typically observed over several days or weeks, depending on the specific infection being treated.


Q: Can Lewimycin interact with common over-the-counter pain relievers?

A: Official drug documents list interactions with specific prescription medications like oral anticoagulants and loop diuretics. Patients are generally advised to discuss all medicines, including over-the-counter pain relievers, vitamins, or supplements, with a healthcare provider before starting treatment.


Q: Is it safe to drink coffee while taking Lewimycin?

A: According to general regulatory guidelines and patient information, there are no known restrictions on consuming coffee or other caffeinated products while using this medication.


Q: What if I accidentally miss a dose of Lewimycin?

A: The official administration guidelines state that the missed dose should be taken as soon as it is remembered. If it is almost time for the next scheduled dose, the guideline is to skip the missed dose and continue with the regular schedule. It is important not to take two doses at the same time.


Q: Can Lewimycin affect my mood or cause anxiety?

A: Yes, regulatory warnings state that central nervous system (CNS) effects are a listed risk, which can include anxiety, depression, confusion, and agitation. Official guidance notes that if these reactions occur, the medicine generally requires immediate discontinuation. Any side effects should be reported to a healthcare professional.


Q: What's the typical time frame for seeing an improvement with Lewimycin?

A: Clinical studies often measure improvement in physical signs (clinical success) within seven to fourteen days for common infections like skin or urinary tract infections. The total duration of therapy is based on the severity of the condition and the specific course prescribed by the healthcare provider.


Q: What should I do if the side effects of Lewimycin bother me?

A: Regulatory guidelines state that if signs of serious side effects (like tendon issues, nerve damage, or severe allergic reactions) occur, the medicine must be discontinued immediately and medical help should be sought. For other side effects that are less severe but still bothersome, patients are advised to contact their healthcare provider.


Q: Are there any restrictions on driving while taking Lewimycin?

A: Since Lewimycin can cause central nervous system effects such as confusion, dizziness, or impaired balance, patients are cautioned that these effects may temporarily impair the ability to drive or safely operate machinery.


Q: Can I take other prescription medications while on Lewimycin?

A: Yes, but caution is necessary. Official documents list specific interactions with certain drugs, including Probenecid and Metformin. Patients are advised to inform their healthcare provider of all prescription medications they are currently taking because of the potential for interactions.


Q: Is it normal to feel a mild headache after starting Lewimycin?

A: Official patient information and side effect profiles list headache as a possible side effect of the medication. Any headache that becomes severe or persistent should be discussed with a healthcare provider.


Q: What happens if I stop taking Lewimycin suddenly?

A: For antibiotics, stopping treatment prematurely carries the risk of the infection returning, and it can also promote the development of drug-resistant bacteria. Therefore, it is important to complete the full prescribed course of the medication, even if symptoms begin to improve.


Q: Does Lewimycin make you feel tired or sleepy?

A: Official drug information lists extreme tiredness and fatigue among the potential side effects reported with the use of this medication.


Q: Are there any foods I should avoid when using Lewimycin?

A: Generally, there are no specific foods that must be avoided. However, the oral form of the medicine must be taken at least two hours before or after when taking multivalent cation-containing products (like certain supplements or antacids) to help ensure proper drug absorption.


Q: Can children take Lewimycin?

A: Yes, official administration guidelines include specific dosing information for pediatric patients, with dosages typically based on the child's weight for certain indications. The eligibility for use in any child should be determined by a healthcare provider.


Q: Does Lewimycin cause stomach upset or nausea?

A: Yes, according to official side effect profiles, common adverse reactions with this antibiotic include nausea, vomiting, stomach pain, and diarrhea.


Q: Has Lewimycin been studied in pregnant women?

A: Animal reproduction studies have not demonstrated risk, but official labeling states there are currently no adequate and well-controlled studies specifically conducted in pregnant women. The use of this medication during pregnancy is a decision that should be made in consultation with a healthcare professional.


Q: Is there a generic version of Lewimycin available?

A: Yes, the active ingredient in Lewimycin is Cephalexin. Cephalexin is a well-established medication that is widely available in generic formulations.


Q: Are long-term side effects a concern with Lewimycin?

A: Official research summaries note that the follow-up period in clinical trials has typically been short, meaning that the long-term effects are not fully established. Patients who require long-term treatment are advised to discuss potential risks and benefits with their healthcare provider.


Q: Does Lewimycin interact with birth control pills?

A: Official documentation notes that Lewimycin may lead to decreased therapeutic efficacy of birth control that contains oestrogen. Patients using hormonal birth control are advised to consult their healthcare provider about this potential interaction.


Q: What happens if I take more Lewimycin than prescribed?

A: Symptoms reported in cases of overdose may include severe reactions such as nausea, vomiting, diarrhea, stomach pain, and changes in the color of the urine. If a suspected overdose occurs, immediate medical attention should be sought.


Q: Does Lewimycin have any known interactions with alcohol?

A: While a severe drug interaction is not typically expected, general patient safety information notes that alcohol consumption is often discouraged during antibiotic treatment. This is because alcohol may intensify some side effects, such as nausea, vomiting, or dizziness.


Q: Is Lewimycin used for chronic or short-term conditions?

A: Lewimycin is used to treat acute bacterial infections. Treatment courses vary widely depending on the type and severity of the infection, with durations ranging from as short as a few days to potentially two months for specific prophylactic (preventative) uses.


Q: Does taking Lewimycin cause any changes in sleep patterns?

A: Official warnings regarding central nervous system (CNS) effects list insomnia (difficulty sleeping) as a possible adverse reaction. Significant changes in sleep patterns should be reported to a healthcare provider.


Q: How long after stopping Lewimycin will it be completely out of my system?

A: The drug’s half-life (the time it takes for half the drug to be eliminated) is approximately one hour. Because of this relatively fast elimination, Lewimycin is considered to be substantially eliminated from the body within 8 to 12 hours after the final dose.


Q: Is there a specific time of day best for taking Lewimycin?

A: Official administration guidelines state that the medicine is generally administered Once Daily (q24h) and can be taken with or without food. This offers flexibility for consistent daily dosing.


Q: What if I feel better before I finish the Lewimycin prescription?

A: Official guidelines emphasize the importance of completing the full prescribed duration of antibiotic therapy, even if symptoms begin to improve. Stopping early can increase the risk of the infection returning and may contribute to antibiotic resistance.


Q: What kind of monitoring is needed while taking Lewimycin?

A: Official documents advise that close monitoring is required for patients who have marked kidney function issues, as the drug is primarily cleared by the kidneys. The need for and type of monitoring are determined by the prescribing healthcare provider.


Q: Can Lewimycin affect my blood sugar levels?

A: Yes, blood sugar disturbances are a known risk. Official warnings report both hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) have occurred, particularly in older patients and those with pre-existing diabetes.

How should Lewimycin be stored and disposed of?

The required storage conditions for Lewimycin (Cephalexin) are defined by regulatory documents and depend on the specific dosage form, ensuring product stability and integrity.

Storage Requirements by Form

Product Form Temperature Constraint Stability/Handling Rule
Capsules/Tablets/Dry Powder Store at controlled room temperature (e.g., 20 C to 25 C); Do not freeze. Protect from moisture; keep in the original container.
Reconstituted Suspension Store in a refrigerator (e.g., 2 C to 8 C); Do not freeze. Discard unused portion after 14 days; shake well before use.

All forms of the medicine must be stored out of the sight and reach of children.

Official Disposal Instructions

Expired or unused Lewimycin should be disposed of by using an authorized drug take-back program. If a take-back program is unavailable, official guidelines recommend mixing the medicine with an undesirable substance (such as dirt or coffee grounds), sealing it in a container, and placing it in household trash. Regulatory rules mandate that the product must not be flushed down the toilet or poured down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lewimycin found in:

A-Z Index: